The Latest Breaking News from Disease

DULUTH, Minn. — Deer hunters across Minnesota will have about the same opportunities to bag a deer or two this fall compared to last, except in parts of northern Minnesota, where a deep-snow winter pushed the Department of Natural Resources to reduce the number of antlerless deer permits in an…

Presence of virus in wastewater indicates people in the community could be shedding virus in their stool, CDC says

A New York man who has been left paralysed has suffered the same polio strain as found in London and Jerusalem it has been confirmed by the US Centers for Disease Control and Prevention

Have you ever thought about donating your brain to science? Don’t worry, I mean after you die.

On July 23, World Health Organisation Director-General Tedros Adhanom Ghebreyesus took the unprecedented step and declared the monkeypox outbreak a “public health emergency of international concern” – the highest global alert level for a disease outbreak.

President Joe Biden is set to name top officials from the Federal Emergency Management Agency and the Centers for Disease Control and Prevention to serve as the White House coordinators to combat the growing monkeypox outbreak

Thailand's first batch of 1,000 monkeypox vaccine doses is expected to arrive later this month, but the authorities have yet to decide who should get them first, according to the Department of Disease Control (DDC).

The governor called it a “a rare, but potentially serious disease that requires the full mobilization of all available public health resources to prevent the spread.” The proclamation allows public health officials to better coordinate efforts with the federal government and other state agencies…

The U.S. Food and Drug Administration (FDA) has cleared the Eledon Pharmaceuticals’ (NASDAQ:ELDN) Investigational New Drug (IND) application to evaluate Tegoprubart for the prevention of organ rejection in patients receiving a kidney transplant. Eledon shares traded in a range of $2.89 to $3.16 on a day volume of 31.27 thousand…

Alzheimer’s disease is the most prevalent form of dementia and, with a rapidly ageing global population, it is fuelling unprecedented demand for costly patient care. There have been an estimated 400 clinical studies since the first Alzheimer’s drug trial in 1987.

Scientists call the name "discriminatory and stigmatizing." The World Health Organization agrees. But no progress has been made on finding a new name. And some say the name doesn't need changing.